Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Pfizer’s stock surged up to 11 percent after the pharma giant reported a robust 85 percent year-on-year rise in net profit ...

There are instances where high-yielding stocks can simply be great deals. Three stocks that pay at least 6% and don't look ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...

Stock Market Today: The Indian stock market opened on a cautious note on Monday, May 19, as they defied the global stock ...

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Gujarat Gas Limited, Quess Corp, Power Finance Corporation, and Eris Lifesciences Limited will also report their quarterly ...